The M2 protein from influenza A virus is a pH-activated proton channel that mediates acidification of the interior of viral particles entrapped in endosomes. M2 is the target of the anti-influenza drugs amantadine and rimantadine; recently, resistance to these drugs in humans, birds and pigs has reached more than 90% (ref. 1). Here we describe the crystal structure of the transmembrane-spanning region of the homotetrameric protein in the presence and absence of the channel-blocking drug amantadine. pH-dependent structural changes occur near a set of conserved His and Trp residues that are involved in proton gating 2 . The drug-binding site is lined by residues that are mutated in amantadine-resistant viruses 3, 4 . Binding of amantadine physically occludes the pore, and might also perturb the pK a of the critical His residue. The structure provides a starting point for solving the problem of resistance to M2-channel blockers.
Although models of the M2 channel have been proposed on the basis of mutagenesis 5 , molecular dynamics 6-8 and spectroscopic studies 9-11 , high-resolution crystallographic or solution NMR structures have not been available. We therefore solved the structure of a peptide spanning the transmembrane helix of M2 (M2TM) [11] [12] [13] [14] . Like the full-length protein, M2TM associates into a tetrameric four-helix bundle that binds amantadine 9,13 and conducts protons 10 . Several functional variants of M2TM 15 were screened for their ability to form diffraction-quality crystals. A crystal form that diffracts to 2.0 Å resolution was obtained from a peptide, in which Ile 33 was changed to selenomethionine (I33-SeMet), at pH 7.3 in the absence of amantadine. The peptide crystallizes with six octyl-b-Dglucopyranoside detergent molecules that form a bilayer-like environment into which M2TM tetramers are embedded ( Supplementary  Fig. 1) . A second mutant, G34A, was crystallized at a lower pH (pH 5.3) in the presence of amantadine (diffraction limit, 3.5 Å resolution). The two structures are very similar (root mean squared deviation, r.m.s.d., for all atoms is 1.8 Å ), with the primary differences lying near the carboxy-terminal region of the helices.
In both structures the tetrameric M2TM helices form a lefthanded, parallel bundle (Fig. 1a) that resembles a conical frustum (a truncated cone), with the narrow amino-terminal end facing the exterior of the viral envelope. Each helix is preceded by a polar, highly conserved sequence, Ser-Ser-Asp (Fig. 1a) , four copies of which form a narrow, solvent-filled pore lined by Ser hydroxyls and main-chain carbonyl groups. Protons pass through this extra-viral vestibule en route to the section of the transmembrane pore formed by the four-helix bundle (residues 25-45, Fig. 1a ). The N-terminal half of the channel has nearly exact four-fold rotational symmetry; the helices are tilted by 35u 6 2u with respect to the central axis of the bundle, which is within the range of 30u to 40u observed by solid-state NMR (ssNMR) for both M2TM
14,16 and a longer fragment of the protein 14 . The pore is most constricted near Val 27; beyond this point it opens to create an aqueous cavity lined by small residues (Ala 30, Ser 31 and Gly 34), reaching a maximal diameter of 9 Å at Gly 34 near the centre of the bilayer. Similar large aqueous cavities are often observed near the centre of channel proteins, where they seem to minimize the thermodynamic cost of bringing a charged ion to the centre of a bilayer 17 . The channel constricts again at the critical pHgating residues His 37 and Trp 41.
Full-length M2 is inhibited by amantadine with a cooperativity factor of 1.0 (ref. 18); the protein binds a single drug molecule per tetramer 19 . The electron-density map from crystals grown in the presence of amantadine shows strong density of the same size and shape as that of this drug molecule (Fig. 1b) . The drug is surrounded by residues (including Val 27, Ala 30, Ser 31 and Gly 34) that are mutated in clinical isolates of amantadine-resistant viruses 1,4,20 . The same hotspot for amantadine resistance was pinpointed in positional scanning mutagenesis of the full-length protein 2, 5 ( Fig. 1b, c) . Furthermore, residues that can be mutated without affecting amantadine inhibition 2,5 lie more distal to the drug-binding site at membrane-accessible and C-terminal locations (including Leu 38 to Asp 44) 2, 5 . The structure is in agreement with electrophysiological studies of full-length M2 that showed that the rate of channel block is approximately 10 5 -fold slower than that expected for diffusion of a small molecule into a channel with a large extracellular opening 18 . The highly restricted vestibule helps to explain the slow kinetics of entry of the drug, which might enter the site by means of rare conformational changes or laterally from the bilayer phase.
The drug-binding site is nearly identical (r.m.s.d. 5 0.4 Å over all atoms of Val 27, Ala 30, Ser 31 and Gly 34) between the amantadinebound (low pH) and the drug-free (high pH) crystal structures; this is consistent with amantadine's known ability to inhibit between pH 5.0 and pH 8.0 (refs 9, 18, 19) . Given the resolution of the structure, two orientations of the drug are possible: the amine group could either point towards the viral exterior or point inward, where it would be hydrated in the aqueous pore (Fig. 1b) . The drug fits the density better in the inward orientation with its large, apolar group snugly fit into the N-terminal end of the aqueous cavity (Fig. 1b, c) . The polar end of the drug projects towards, but does not directly contact, His 37. This binding mode is consistent with the fact that if the amino group of amantadine is substituted with structurally diverse bulky secondary alkylamines, inhibitory activity is retained 21 . Long-range interactions between the ammonium group and His 37 might also account for shifts in this residue's pK a that accompany the binding of the drug 9 . The recent, marked rise in amantadine resistance has been associated with a single mutation, S31N (ref. 20) . In the 2005-2006 flu season, resistance reached more than 90%, and 99.9% of the resistant viruses collected worldwide (1,059 of 1,060) had the S31N mutation 1 . Asn can be modelled in a low-energy rotamer at position 31 of the crystal structure, resulting in extensive hydrogen bonding between the Asn carboxamides ( Supplementary Fig. 2 ). The side chains form a carbonyl-lined hole that can accommodate one or more water molecules, explaining the retention of proton-channel activity in this mutant. This mutation also constricts the size and increases the polarity of the amantadine-binding site-features that should interfere with the binding of the large hydrophobic adamantane group. Furthermore, Ser-to-Asn mutations stabilize transmembrane helixhelix association 22 . Thus, the S31N mutation seems to be particularly fit in terms of its ability to allow proper insertion, assembly and function of M2 in membranes, while escaping inhibition by amantadine. Interestingly, although S31N constricts the amantadinebinding site in the N-terminal half of the transmembrane pore, this mutation does not fill the aqueous pore adjacent to His 37 and Trp 41-functionally essential residues conserved in all influenza A and B viruses. New drugs that bind this region might inhibit both Ser 31 and Asn 31 variants of M2, and they should also be less susceptible to the development of new resistance.
The crystal structures at neutral and low pH provide insight into the role of His 37 and Trp 41 in the conduction of protons. These residues lie near the channel exit within the wide end of the bundle. In the low-pH structure, all four helices are straight and diverge from a point where the helical axes most closely approach the central fourfold symmetry axis, which occurs in the vicinity of Val 27. This divergence creates to a large opening near His 37 and Trp 41. However, the pore of the neutral-pH form is smaller and less symmetric; helix D has a gradual bend of 15u near Gly 34, allowing Trp 41 D (the subscript refers to helical subunit D) to interact with His 37 C in an edge-on aromatic interaction (Fig. 2a, b ) previously predicted from spectroscopic 11 and ssNMR 23 measurements. This conformation is further stabilized by an interhelical salt bridge between Arg 45 D and Asp 44 C (Fig. 2a, b ). In contrast, the A and B helices are more similar to the symmetrical low-pH form. They are nearly completely straight and consequently diverge too far to allow interhelical His-Trp and ArgAsp interactions (Fig. 2a, c) .
The finding of multiple conformations at the gating end of the channel is consistent with the known pH-dependent dynamic and functional properties of M2. The neutral form was crystallized at pH 7.3, at which the four His 37 residues should be in a mixed protonation state on the basis of their known pK a values in M2TM 26 . Interestingly, the low-pH form was solved using the G34A mutation; if this region is indeed part of a hinge, this mutation might help to stabilize an open conformation with straight rather than curved helices.
To explore the functional implications of the conformational differences in the subunits of the neutral-pH form, we superimposed chains A, B, C and D of M2TM onto B, C, D and A, respectively, and repeated this procedure for each of the remaining cyclic permutations (Fig. 3a) . The resulting family of four tetramers superpose extremely well at the N terminus of the bundle, but become increasingly divergent at the C terminus. The four copies of helix A form a bundle, designated A4, in which the straight helices diverge near the C terminus as in the low-pH structure (Fig. 3b, r. m.s.d. 5 1.5 Å over all atoms). At the other extreme, the D4 bundle, which is almost completely closed at the C terminus of the bundle, is similar to a coiled-coil ( Fig. 3c-e) . The A4 and D4 models suggest a minimal mechanism for the pH-dependent activation of the channel (Fig. 4) . At high-pH values, the channel would be mostly in a D4-like 'closed' state, whereas a decrease in pH would trigger electrostatic repulsions between multiple protonated His residues to a more open A4-like state with improved hydration of the charged His side chains 6,7 . This mechanism is in agreement with the effects of mutations on the pH-dependent activation of the channel. The His C -Trp D and Arg D -Asp C interactions seen in the helix C-D interface of the crystal structure (Fig. 2b) and at each interface in the D4 bundle ( (Fig. 3e) .
The structure-based model for the open state (A4 tetramer) is also consistent with the electrophysiological properties of M2. Although M2 is considered to be a channel, it has a very low maximal conductance rate of less than 10 4 protons per second (ref. 28)-much lower than that of typical ion channels, which usually have maximal rates of 10 5 to 10 7 ions per second. The slow rate of M2 is consistent with the restricted channel vestibule and argues against a highly populated open state with either a very large pore or an uninterrupted organized 'wire' of water molecules. Furthermore, His 37 lies about two-thirds of the way through the transmembrane electrical field 28, 29 , which also argues against a large (.10 Å ) uninterrupted pore leading from the outside of the virus to His 37 that would place this residue near the beginning of the transmembrane potential gradient. Instead, the highly restricted N-terminal vestibule might contribute to proton selectivity. N-terminal motions would allow protons to penetrate into the aqueous pore by means of transient hydrogen-bonded chains of water molecules, whereas it might be very difficult for hydrated sodium or potassium to penetrate this region. Indeed, amantadinesensitive variants in which Val 27, which lines the most constricted point in the pore, is mutated to Ser, Thr or Cys have increased conductance and/or compromised ion selectivity 5,30 . Earlier predictions are in reasonable accord with the crystallographic structures in terms of many of the overall features of the channel. The r.m.s.d. between experimentally restrained models on the basis of site-directed mutagenesis and conformational searching 5,15 is 3 Å to 4 Å , and these models accurately predicted the location of critical residues in the pore. The helix-crossing angles of the crystallographic structures are within the range of angles detected by ssNMR studies of M2TM 14,16 in buffered solution. Early attempts to define models on the basis of restraints from ssNMR were complicated by conformational averaging 9,10,25 . However, a recent study of the amantadine complex at high pH (ref. 25) showed a conformation for the helical monomer in excellent agreement with the bent helix D of the crystal structure (15u versus 11u by ssNMR 25 ). A model based on these ssNMR angular restraints is consistent with the overall features of the crystallographic structures and the D4 model (allatom r.m.s.d. 5 ,3.0 to ,3.3 Å ).
The crystallographic structures are in excellent agreement with a wide body of functional and spectroscopic data and provide a basis for the design of new inhibitors that target amantadine-resistant mutants of M2. Inhibitors that target the cavity adjacent to the highly conserved His 37 and Trp 41 residues might reclaim the M2-blocking class of drugs both for prophylaxis and for treatment of ongoing endemic outbreaks and future pandemics of this deadly pathogen.
Note added in proof: An accompanying manuscript describes an NMR solution structure of a peptide comprising residues 18-60 of M2. We believe that this structure represents a biologically relevant closed form of the channel that is unable to bind amantadine in its central cavity 31 .
METHODS SUMMARY
Crystals were grown by the hanging-drop method. X-ray data were phased by molecular replacement. Refinement methods and statistics are provided in the Methods; all residues were located in the most favourable region of the Ramachandran plot.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. Supplementary Information is linked to the online version of the paper at www.nature.com/nature.
METHODS
Solid-phase peptide synthesis. The sequence of wild-type M2TM is SSDPLVV-AASIIGILHLILWILDRL. Single-site variants of M2TM were chemically synthesized using solid-phase peptide synthesis with 9-fluorenylmethoxycarbonyl (Fmoc) chemistry 32 . Cleavage from resin and deprotection of amino acid protecting groups was carried out in a mixture of trifluoroacetic acid (TFA)/ triisopropyl silane/H 2 O (90:5:5 v/v) at room temperature (25 uC) under nitrogen for four hours. Purification proceeded by reverse-phase high-performance liquid chromatography (HPLC) using a preparative C4 column (Vydac) and a linear gradient of buffer A (99.9% H 2 O and 0.1% trifluoroacetic acid) and buffer B (60% acetonitrile, 30% isopropanol, 9.9% H 2 O and 0.1% trifluoroacetic acid). The purity and molecular mass of M2TM peptides were assessed by analytical HPLC on a C4 column and matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry. Crystallization. Crystals of selenomethionine-labelled M2TM segment (I33-SeMet) were grown by the hanging-drop vapour diffusion method by mixing equal volumes of protein solution and well solution. Initial attempts at crystallization showed that the protein crystallized from approximately 20% PEG MME (polyethylene glycol monomethyl ether) at a variety of pH values. Additive screens showed that xylitol and MgCl 2 improved the quality of the crystals. These were combined to provide crystallization conditions consisting of equal volumes of: solution A (1 mM protein, 50 mM octyl-b-D-glucopyranoside and 5% w/v xylitol) and solution B (50 mM Tris-HCl, 0.5 M MgCl 2 , 21% PEG 350 MME). The final pH after addition of all components was 7.3.
A similar additive screen showed that Ni(II) also improved diffraction. M2TM-segment G34A mutant crystals were obtained using the hanging-drop vapour diffusion method by mixing equal volumes of the protein solution (0.8 mM protein, 0.6 mM amantadine, 32 mM octyl-b-D-glucopyranoside and 5% w/v xylitol) with pH 8 reservoir solution (50 mM Tris-HCl, 0.5 mM MgCl 2 , 30 mM NiCl 2 and 22% PEG 350 MME). We found that the Tris buffer interacted with NiCl 2 and/or other components of the buffer, resulting in release of protons and reducing the pH of the solution to 5.3. X-ray diffraction data collection and processing. Synchrotron data for the M2TM I33-SeMet crystal were collected on beamline X12-C at the National Synchrotron Light Source, Brookhaven National Laboratory. Three multiwavelength anomalous diffraction data sets were collected. During data collection, the crystal was cryo-cooled to 100 K. The data sets were processed using DENZO and SCALEPACK 33 . The crystals were found to belong to space group P2 1 , and the diffraction data were processed to a maximum resolution of 2.0 Å . The crystallographic details are shown in Supplementary Table 1. Crystals of M2TM(G34A) were cryo-cooled to 100 K, and the diffraction data were collected on a diffractometer equipped with Cu (K a ) radiation and a MAR image plate detector (345 mm) at the home source. The data sets were integrated with DENZO and were scaled with SCALEPACK 33 . The crystal belongs to the space group P2 1 2 1 2 and was diffracted to a maximum resolution of 3.5 Å (Supplementary Table 1 ) suggested four molecules in the asymmetric unit with a solvent content of 58.6 for the G34A data. The structure solution was obtained by the molecular replacement method using a polyalanine a-helix of 23 residues in length as a search probe. Molecular-replacement calculations were performed using the program PHASER 35 and using the data in the resolution range 13.0-4.0 Å .
The initial model obtained was subjected to iterative model building and refinement. Initially, a few cycles of model refinement were done using CCP4 suite REFMAC 36, 37 and then by CNS 38 . When all the side chains were included during the model building, a few cycles of simulated annealing refinement were carried out using the program suite CNS 38 . At the later stages of refinement, REFMAC 37 was used. Supplementary Table 1 gives the statistics of the final structure. The model building was carried out using COOT 39 ). Preliminary analyses using XPREP 40 on three wavelength data sets suggested the presence of anomalous signals up to 3.6 Å resolution. Attempts to obtain experimental phases from anomalous signals by MAD as well as SAD approaches were not successful. Molecular replacement using a single a-helix as a search model was also not successful, but succeeded when the initial solution for the M2TM(G34A) structure was used as the search model. Molecular replacement was carried out using PHASER 35 on peak data sets in the resolution range 15.0-4.0 Å . Iterative refinement and model building were carried out on the initial model. During the initial stages, all side chains could be traced in the electron density map. As the refinement progressed, detergent (octyl-b-D-glucopyranoside) and PEG 350 MME molecules were located in the electron density map. The refinement was facilitated by applying non-crystallographic restraints on the two tetramers in the asymmetric unit. Release of the noncrystallographic symmetry restraints failed to improve the refinement statistics, so the two tetramers were considered to be identical. Supplementary Table 1 shows the refinement and final model statistics. The refinement was carried out using CCP4 (ref. 35) program suite REFMAC 37 and all the model building was done using COOT 39 . Computational studies. Each C 4 -symmetric tetramer (designated A4, B4, C4 or D4, depending on which monomer was used) was constructed by optimally superimposing the Ca atoms of residues 22-32 onto a cyclically permuted tetramer. For example, to generate the A4 tetramer, Ca atoms from residues 22-32 from chains (A, B, C, D) were optimally superimposed onto Ca atoms from residues 22-32 from chains (A, B, C, D), (B, C, D, A), (C, D, A, B) and (D, A, B, C). Chain A from each optimally superimposed structure was then relabelled (A, B, C and D, respectively) and used to construct the A4 tetramer. The same procedure was used to construct the B4, C4 and D4 tetramers.
Energy minimization was carried out using the XPLOR-NIH 41 (version 1.1.2) implementation of the CHARMM22 force field. Histidines on chains A and C were doubly protonated and histidines on chains B and D were singly protonated on the e nitrogen. Hydrogen atoms were added to each structure using the 'HBUILD' routine followed by 1,000 steps of Powell minimization using a distance-dependent dielectric constant with e 5 4.
The kink angle was defined as the angle of deviation between best-fit lines through the N-terminal and C-terminal halves of a helix. For each helix of the tetramer, the N-terminal region consisted of residues 25-34 and the C-terminal region consisted of residues 35-46. Using Ca atoms only, best-fit lines through each region of the helix were constructed using a modified version of an existing algorithm 42 . Coordinates for all models can be obtained by contacting C.S.S.
